Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Jiang, Wei ^a   Chen, Xiaowen ^a   Liao, Mingzhi ^a,b   Li, Wei ^a   Lian, Baofeng ^a   Wang, Lihong ^a   Meng, Fanlin ^a   Liu, Xinyi ^a   Chen, Xiujie ^a   Jin, Yan ^a   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; NEOPLASM;

GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 84859762550     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00282     Document Type: Article

References (57)

1. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116, 281-297 (2004).
2. Esquela-Kerscher, A. & Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6, 259-269 (2006).
3. Sevignani, C., Calin, G. A., Siracusa, L. D. & Croce, C. M. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome. 17, 189-202 (2006). (Pubitemid 43327650)
4. Yang, Q., Qiu, C., Yang, J., Wu, Q. & Cui, Q. miREnvironment database: providing a bridge for microRNAs, environmental factors and phenotypes. Bioinformatics. 27, 3329-3330 (2011).
5. Zhang, S., Chen, L., Jung, E. J. & Calin, G. A. Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther. 87, 754-758 (2010).
6. Spizzo, R., Rushworth, D., Guerrero, M. & Calin, G. A. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma. 9 Suppl 3, S313-318 (2009).
7. Pan, Q., Tilanus, H. W., Janssen, H. L. & van der Laan, L. J. Prospects of RNAi and microRNA-based therapies for hepatitis C. Expert Opin Biol Ther. 9, 713-724 (2009).
8. Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 327, 198-201 (2010).
9. Gumireddy, K. et al. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl. 47, 7482-7484 (2008).
10. Blower, P. E. et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther. 7, 1-9 (2008).
11. Gusev, Y., Schmittgen, T. D., Lerner, M., Postier, R. & Brackett, D. Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer. BMC Bioinformatics. 8 Suppl 7, S16 (2007).
12. Bertino, J. R., Banerjee, D. & Mishra, P. J. Pharmacogenomics of microRNA: a miRSNP towards individualized therapy. Pharmacogenomics. 8, 1625-1627 (2007).
13. Yang, H. et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433 (2008). (Pubitemid 351380068)
14. Iorio, F. et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA. 107, 14621-14626 (2010).
15. Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 313, 1929-1935 (2006). (Pubitemid 44497995)
16. Rhodes, D. R. et al. Oncomine 3. 0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles. Neoplasia. 9, 166-180 (2007).
17. Vanhaecke, T., Papeleu, P., Elaut, G. & Rogiers, V. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr Med Chem. 11, 1629-1643 (2004). (Pubitemid 38735799)
18. Shankar, S. & Srivastava, R. K. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis. Adv Exp Med Biol. 615, 261-298 (2008).
19. Zhang, Z. W., An, Y. & Teng, C. B. [The roles of miR-17-92 cluster in mammal development and tumorigenesis]. Yi Chuan. 31, 1094-1100 (2009).
20. Gottardo, F. et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 25, 387-392 (2007). (Pubitemid 47362758)
21. Wang, T. et al. Amicro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 46, 336-347 (2007). (Pubitemid 46411325)
22. Karabulut, B. et al. Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer. J Exp Clin Cancer Res. 29, 102 (2010).
23. Sos, M. L. et al. Identifying genotype-dependent efficacy of single and combined PI3K-and MAPK-pathway inhibition in cancer. Proc Natl Acad Sci USA. 106, 18351-18356 (2009).
24. Yang, Q. & Guan, K. L. Expanding mTOR signaling. Cell Res. 17, 666-681 (2007). (Pubitemid 47255937)
25. Brest, P. et al. MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells. Endocr Relat Cancer. 18, 711-719 (2011).
26. Chen, Y. et al. Methyl-CpG binding protein MBD2 is implicated in methylationmediated suppression of miR-373 in hilar cholangiocarcinoma. Oncol Rep. 25, 443-451 (2011).
27. Zhang, S., Cai, X., Huang, F., Zhong, W. & Yu, Z. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. Exp Oncol. 30, 265-268 (2008).
28. Li, W. et al. Integrative analysis of many weighted co-expression networks using tensor computation. PLoS Comput Biol. 7, e1001106 (2011).
29. Jayaswal, V., Lutherborrow, M., Ma, D. D. & Yang, Y. H. Identification of microRNA-mRNA modules using microarray data. BMC Genomics. 12, 138 (2011).
30. Zheng, S., Tansey, W. P., Hiebert, S. W. & Zhao, Z. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. BMC Med Genomics. 4, 62 (2011).
31. Marras, E., Travaglione, A., Chaurasia, G., Futschik, M. & Capobianco, E. Inferringmodules from human protein interactome classes. BMC Syst Biol. 4, 102 (2010).
32. Lin, D. An information-theoretic definition of similarity. Proceeding of the 15th International Conference on Machine Learning, San Francisco. (1998).
33. Campillos, M., Kuhn, M., Gavin, A. C., Jensen, L. J. & Bork, P. Drug target identification using side-effect similarity. Science. 321, 263-266 (2008). (Pubitemid 351989100)
34. Wishart, D. S. et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901-906 (2008). (Pubitemid 351149842)
35. Martin, Y. C., Kofron, J. L. & Traphagen, L. M. Do structurally similar molecules have similar biological activity? J Med Chem. 45, 4350-4358 (2002). (Pubitemid 35025581)
36. Brentjens, R. & Saltz, L. Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am. 81, 527-542 (2001). (Pubitemid 32612114)
37. Chen, N. & Karantza, V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther. 11, 157-168 (2011).
38. Aft, R. L., Zhang, F. W. & Gius, D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent:mechanism of cell death. Br J Cancer. 87, 805-812 (2002). (Pubitemid 35178760)
39. Zhang, F. & Aft, R. L. Chemosensitizing and cytotoxic effects of 2-deoxy-Dglucose on breast cancer cells. J Cancer Res Ther. 5 Suppl 1, S41-43 (2009).
40. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature. 420, 860-867 (2002). (Pubitemid 36019639)
41. Gatson, J. W. et al. Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling. J Neuroinflammation. 6, 30 (2009).
42. Jayaswal, V., Lutherborrow, M., Ma, D. D. & Yang, Y. H. Identification of microRNA-mRNA Modules using Microarray Data. BMC Genomics. 12, 138 (2011).
43. Li, X. et al. Dissection of humanMiRNA regulatory influence to subpathway. Brief Bioinform. (2011).
44. Rehmsmeier, M., Steffen, P., Hochsmann, M. & Giegerich, R. Fast and effective prediction of microRNA/target duplexes. RNA. 10, 1507-1517 (2004). (Pubitemid 39288185)
45. Kiriakidou, M. et al. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 18, 1165-1178 (2004). (Pubitemid 38669037)
46. Miranda, K. C. et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 126, 1203-1217 (2006). (Pubitemid 44380294)
47. Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36, D154-158 (2008). (Pubitemid 351149713)
48. Enright, A. J. et al. MicroRNA targets in Drosophila. Genome Biol. 5, R1 (2003).
49. Krek, A. et al. Combinatorial microRNA target predictions. Nat Genet. 37, 495-500 (2005). (Pubitemid 40617277)
50. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell. 115, 787-798 (2003). (Pubitemid 38058492)
51. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4, 44-57 (2009).
52. Zhou, X. & Su, Z. EasyGO: Gene Ontology-based annotation and functional enrichment analysis tool for agronomical species. BMC Genomics. 8, 246 (2007).
53. Li, C. et al. SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Res. 37, e131 (2009).
54. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 102, 15545-15550 (2005). (Pubitemid 41528093)
55. Li, Y. et al. Gene expression module-based chemical function similarity search. Nucleic Acids Res. 36, e137 (2008).
56. Wang, Y. et al. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 37, W623-633 (2009).
57. Rahman, S. A., Bashton, M., Holliday, G. L., Schrader, R. & Thornton, J. M. Small Molecule Subgraph Detector (SMSD) toolkit. J Cheminform. 1, 12 (2009).